Ilika Plc Manufacturing agreement for Stereax® with Semefab Ltd

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery technology and materials innovation company, announced today an intended manufacturing partnership with Semefab Ltd for the manufacture of Stereaxâ thin film solid-state cells.

Since 1986, Semefab has produced a diverse portfolio of CMOS, ASIC and semiconductor technologies. Ilika and Semefab have undertaken a detailed review of Ilika’s qualified process for the manufacture of Stereaxâ thin film batteries. Semefab has confirmed that it has the microfabrication know-how to be able to manufacture Stereaxâ cells on an economic basis in quantities suitable for market introduction of products. Semefab has also confirmed that the Ilika process is technically compatible with its facility in Fife, Scotland.

Allan James, Semefab Managing Director, stated: “We believe there is a substantial market opportunity for thin-film microfabricated batteries, which is well-aligned with our current business.”

Graeme Purdy, Ilika plc CEO added: “We are delighted to be working with Semefab, which has a long history of manufacturing MEMS and IC products. Semefab is arguably currently the UK’s leading commercial foundry of such devices. This key manufacturing partnership extends Ilika’s market reach and advances the Company one step closer to a valuable licensing deal.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Search